Business Context and Reporting Period
Company: LightPath Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010 (Third Quarter of Fiscal Year 2010)
Business Overview: The Company manufactures precision molded aspherical lenses, GRADIUM glass lenses, collimators, and isolator optics for industrial, medical, defense, test & measurement, and telecommunications markets. Over 95% of precision molded lenses are manufactured at a wholly-owned subsidiary in Shanghai, China.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2010 | Nine Months Ended Mar 31, 2010 |
|---|---|---|
| Product Sales (Revenue) | $2,660,415 | $6,443,848 |
| Gross Margin | $1,251,059 (47.0%) | $2,877,618 (44.7%) |
| Operating Income (Loss) | $203,278 | $(119,736) |
| Net Income (Loss) | $12,052 | $(652,645) |
| EBITDA | $397,308 | $379,030 |
| Cash and Cash Equivalents | $542,891 | $542,891 |
| Total Debt (Convertible Debentures) | $1,581,916 (Carrying Value) | $1,581,916 (Carrying Value) |
| Accumulated Deficit | $(202,237,986) | $(202,237,986) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 61% in the quarter and 9% for the nine-month period compared to the prior year, driven by higher volumes in precision molded optics and GRADIUM products, despite lower average selling prices.
- Profitability Improvement: The Company reported a net income of $12,052 for the quarter, a significant improvement from a net loss of $756,175 in the same period last year. For the nine months, the net loss narrowed to $652,645 from $3,505,492.
- Gross Margin Expansion: Gross margin percentage improved to 47% in the quarter (from 25% prior year) and 45% for the nine months (from 26% prior year) due to cost reduction initiatives, including shifting production to China and utilizing less expensive glass types.
- Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased by approximately $833,000 for the nine-month period, aided by a one-time $556,000 recovery from a D&O insurance claim and reduced headcount.
- Interest Expense: Interest expense decreased significantly for the nine-month period ($534,449 vs. $1,173,578) due to the conversion of a portion of convertible debentures into common stock.
Guidance, Outlook, and Risks
- Going Concern: The filing states there is substantial doubt about the Company's ability to continue as a going concern due to recurring losses and an accumulated deficit of approximately $202 million. Management believes current cash resources are sufficient to fund operations through April 2011, assuming revenue remains at current levels.
- Outlook: Management expects modest revenue increases in the fourth quarter of fiscal 2010, driven by a backlog of $3.9 million (up from $2.3 million at June 30, 2009). Growth is expected from low-cost lenses in the Asia/Pacific region.
- Capital Needs: The Company recently raised $1.1 million in a private placement in April 2010. Future financing may be required to sustain operations or pursue growth if sales targets are not met.
- Risks: Key risks include dependence on a few key customers, the need for additional financing, potential declines in revenue, and the ability to transition into new markets. The Company has extended payment terms with certain vendors to conserve cash.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $543,000 cash balance (as of March 31) and the $1.1 million raised in April 2010 to cover operations through the projected April 2011 date.
- Debt Obligations: Confirm the repayment schedule for the $2.06 million principal outstanding on 8% convertible debentures due in August 2011.
- Revenue Quality: Assess the concentration of revenue in the "low cost" lens segment and the sustainability of the 61% quarterly revenue growth.
- One-Time Items: Note that the improvement in SG&A was partially driven by a non-recurring $556,000 insurance claim recovery; evaluate operating expenses excluding this item.
- Backlog Conversion: Monitor the conversion of the $3.9 million order backlog into actual revenue to validate management's growth projections.